A new route to L-threo-3-[4-(methylthio)phenylserine], a key intermediate for the synthesis of antibiotics: Recombinant low-specificity D- threonine aldolase-catalyzed stereospecific resolution

37Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A new enzymatic resolution process was established for the production of L-threo-3-[4-(methylthio)phenylserine] (MTPS), an intermediate for synthesis of antibiotics, florfenicol and thiamphenicol, using the recombinant low- specificity D-threonine aldolase from Arthrobacter sp. DK-38. Chemically synthesized DL-threo-MTPS was efficiently resolved with either the purified enzyme or the intact recombinant Escherichia coli cells overproducing the enzyme. Under the optimized experimental conditions, 100 mM (22.8 g l-1) L- threo-MTPS was obtained from 200 mM (45.5 g l-1) DL-threo-MTPS, with a molar yield of 50% and a 99.6% enantiomeric excess.

Cite

CITATION STYLE

APA

Liu, J. Q., Odani, M., Dairi, T., Itoh, N., Shimizu, S., & Yamada, H. (1999). A new route to L-threo-3-[4-(methylthio)phenylserine], a key intermediate for the synthesis of antibiotics: Recombinant low-specificity D- threonine aldolase-catalyzed stereospecific resolution. Applied Microbiology and Biotechnology, 51(5), 586–591. https://doi.org/10.1007/s002530051436

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free